Nicole Harrell, MD
Dermatology · Baton Rouge, LANPI 1972763340
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 611 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,326, 2.1 times the $1,117 reported in 2019.
Across 611 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Amgen$1K
- Sanofi$984
- Novartis$863
- Merz North America, Inc.$401
- plus $3K from 30 others
Across 60 payments — averaging $13,775 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$694K
- Eli Lilly$65K
- AstraZeneca$35K
- Dermira, Inc.$16K
- E.r. Squibb & Sons, L.L.C.$8K
- Kiniksa Pharmaceuticals, Ltd.$7K
- plus $2K from 1 others
What the payments were for
- Food & beverage$9,67998%
- Education$1852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 175 | $2,264 |
| Johnson & Johnson | 69 | $1,043 |
| Amgen | 45 | $1,009 |
| Sanofi | 46 | $984 |
| Novartis | 67 | $863 |
| Merz North America, Inc. | 8 | $401 |
| E.r. Squibb & Sons, L.L.C. | 28 | $375 |
| Sun Pharmaceutical Industries Inc. | 9 | $310 |
| Galderma Laboratories, L.p. | 31 | $303 |
| UCB, Inc. | 14 | $298 |
| Regeneron Healthcare Solutions, Inc. | 12 | $258 |
| Pfizer | 25 | $248 |
| LEO Pharma Inc. | 11 | $196 |
| Lilly USA, LLC | 8 | $131 |
| Boehringer Ingelheim | 6 | $128 |
| Bristol Myers Squibb | 7 | $120 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $113 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $111 |
| Biofrontera Inc. | 6 | $94 |
| Genentech USA, Inc. | 5 | $76 |
| Incyte Corporation | 4 | $68 |
| Botanix SB Inc | 3 | $60 |
| VYNE Pharmaceuticals Inc. | 3 | $55 |
| Almirall LLC | 3 | $45 |
| Dermavant Sciences, Inc. | 3 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Elekta, Inc. | 1 | $34 |
| Mayne Pharma Commercial LLC | 2 | $30 |
| Mimedx Group, Inc. | 1 | $29 |
| Kerecis Limited | 1 | $25 |
| Conmed Corporation | 1 | $20 |
| Journey Medical Corporation | 1 | $18 |
| Dermira, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Convatec Inc. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,864 in reported general payments places this provider in the 75th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 75 | $291,719 |
| Humira(Cf) PenAdalimumab | 21 | $278,128 |
| Taltz AutoinjectorIxekizumab | 13 | $88,147 |
| Dupixent SyringeDupilumab | 19 | $75,102 |
| Clobetasol Propionate | 81 | $2,533 |
| Tacrolimus | 24 | $2,511 |
| Triamcinolone Acetonide | 206 | $1,954 |
| Doxycycline Hyclate | 54 | $1,679 |
| Ketoconazole | 95 | $1,669 |
| Fluocinonide | 54 | $1,383 |
| Metronidazole | 32 | $1,345 |
| Fluorouracil | 20 | $1,238 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 11 | $1,196 |
| Finasteride | 62 | $826 |
| Tretinoin | 16 | $721 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Baton Rouge
- Justin CreelBaton Rouge$199K
- Mamina TureganoBaton Rouge$157K
- Kelli HallBaton Rouge$31K
- Ira ThorlaBaton Rouge$31K
- Sarah McGintyBaton Rouge$18K
- Mary DickersonBaton Rouge$18K
- John BrantleyBaton Rouge$16K
- Amie ShannonBaton Rouge$13K
- Lori ByrdBaton Rouge$12K
- Harry BurglassBaton Rouge$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.